Accrol (AIM: ACRL), the UK's leading independent tissue converter, announces the second grant of options to executive Directors and certain senior management under the Long-Term Incentive Plan ("LTIP") announced on 5 March 2021.
The LTIP was established to incentivise management to deliver long-term value creation for shareholders and ensure alignment with shareholder interests.
Background
The LTIP is based on market standard annual awards and is limited to a maximum of 5% of the issued share capital of the Company over its five year life.
All awards made under the LTIP will be made by the granting of nil-cost options established in accordance with the rules of the LTIP and vesting is subject to adjusted EBITDA targets in line with the LTIP rules.
The Remuneration Committee has discretion to amend these terms to take account of, for example, corporate activities such as acquisitions to ensure that the performance targets remain appropriate. Malus and clawback provisions are also in place to reduce or recover any awards for criteria such as any material misstatement of the financial statements, a serious breach of the Company's code of ethics or a serious health and safety issue.
Award size, performance conditions and dilution
On 17 November 2022, options over 7,387,875 shares in aggregate (the "2023 Awards") were granted under the LTIP, including those set out below which were granted to directors:
| Director / PDMR |
Role |
Number of shares over which 2022 Awards made |
| Dan Wright |
Executive Chairman |
1,153,098 |
| Gareth Jenkins |
Chief Executive Officer |
2,402,287 |
| Richard Newman |
Chief Financial Officer |
650,407 |
The 2023 Awards are subject to the below Adjusted EBITDA targets measured over the performance period ending on 30 April 2025 and are summarised below:
| Adjusted EBITDA for FY2025 |
Percentage of the 2023 Award that may vest |
| Less than £19.0m |
0% |
| Between £19.0m and £21.0m |
between 25% and 100% |
| £21.0m or greater |
100% |
If the maximum targets are met in FY25, the total dilutive impact of the 2023 Awards will be c.2.3%. The maximum aggregate dilutive effect of awards currently in issue that can be exercised under the LTIP remains below 5% of issued share capital.
| For further information, please contact: |
|
| |
|
| Accrol Group Holdings plc |
|
| Dan Wright, Executive Chairman |
Via Belvedere Communications |
| Gareth Jenkins, Chief Executive Officer Richard Newman, Chief Financial Officer |
|
| |
|
| Zeus (Nominated Adviser & Broker) |
|
| Dan Bate / Jordan Warburton (Investment Banking) |
Tel: +44 (0) 161 831 1512 |
| Dominic King (Corporate Broking) |
Tel: +44 (0) 203 829 5000 |
| |
|
| Liberum Capital Limited (Joint Broker) |
Tel: +44 (0) 20 3100 2222 |
| Clayton Bush / Edward Thomas |
|
| |
|
| Belvedere Communications Limited |
|
| Cat Valentine |
Tel: +44 (0) 7715 769 078 |
| Keeley Clarke |
Tel: +44 (0) 7967 816 525 |
| |
accrolpr@belvederepr.com |
| |
|
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the £2.1bn UK retail tissue market.
The below information and notification is made in accordance with the EU Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
|
1
|
Details of the person discharging managerial responsibilities / person closely associated |
| a) |
Name |
Dan Wright |
| 2 |
Reason for the notification |
| a) |
Position/status |
Executive Chairman |
| b) |
Initial notification /Amendment |
Initial notification |
| 3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
| a) |
Name |
Accrol Group Holdings plc |
| b) |
LEI |
213800MC56M5G69RJ226 |
| 4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of £0.001 each ISIN: GB00BZ6VT592 |
| b) |
Nature of the transaction |
Grant of options over ordinary shares under the Company's new LTIP
|
| c) |
Price(s) and volume(s) |
Volume: 1,153,098
Price : £0.001
|
| d) |
Aggregated information - Aggregated volume - Price |
n/a |
| e) |
Date of the transaction |
17 November 2022 |
| f) |
Place of the transaction |
Off market transaction
|
|
1
|
Details of the person discharging managerial responsibilities / person closely associated |
| a) |
Name |
Gareth Jenkins |
| 2 |
Reason for the notification |
| a) |
Position/status |
Chief Executive Officer |
| b) |
Initial notification /Amendment |
Initial notification |
| 3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
| a) |
Name |
Accrol Group Holdings plc |
| b) |
LEI |
213800MC56M5G69RJ226 |
| 4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of £0.001 each ISIN: GB00BZ6VT592 |
| b) |
Nature of the transaction |
Grant of options over ordinary shares under the Company's new LTIP
|
| c) |
Price(s) and volume(s) |
Volume: 2,402,287
Price : £0.001
|
| d) |
Aggregated information - Aggregated volume - Price |
n/a |
| e) |
Date of the transaction |
17 November 2022
|
| f) |
Place of the transaction |
Off market transaction
|
|
1
|
Details of the person discharging managerial responsibilities / person closely associated |
| a) |
Name |
Richard Newman |
| 2 |
Reason for the notification |
| a) |
Position/status |
Chief Financial Officer |
| b) |
Initial notification /Amendment |
Initial notification |
| 3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
| a) |
Name |
Accrol Group Holdings plc |
| b) |
LEI |
213800MC56M5G69RJ226 |
| 4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of £0.001 each ISIN: GB00BZ6VT592 |
| b) |
Nature of the transaction |
Grant of options over ordinary shares under the Company's new LTIP
|
| c) |
Price(s) and volume(s) |
Volume: 650,407
Price : £0.001
|
| d) |
Aggregated information - Aggregated volume - Price |
n/a |
| e) |
Date of the transaction |
17 November 2022 |
| f) |
Place of the transaction |
Off market transaction
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
